Aerosol treatment with RU 41821, a glycoprotein extract from Klebsiella pneumoniae, was tested in mice for its effect on the kinetics of the induction of bronchoalveolar cells (i.e., alveolar macrophages, monocytes, lymphocytes, and polymorphonuclear leukocytes). RU 41821 led to an increase in the total number of bronchoalveolar celis. The largest increase was observed for polymorphonuclear leukocytes, and more moderate increases occurred in the numbers of alveolar macrophages, monocytes, and lymphocytes. The alveolar macrophages recruited in response to RU 41821 were activated, as indicated by luminol-dependent chemiluminescence in response to stimulation by opsonized zymosan. The effects of five RU 41821 aerosol treatments and those of a single treatment were further examined in vivo by aerosol infection of mice inoculated with a mouse-pathogenic influenza virus. The maximum protective effect was obtained after five once-a-day treatments and was correlated with the largest increase in the total number of bronchoalveolar cells.
The development of bronchoalveolar washing (BAW) techniques has permitted the recovery of macrophages from animals (10, 21) and from humans (23) . A key role for these cells in the early events of the immune responses to lung infections has been demonstrated (4, 6) . However, although products of bacterial origin are widely used as immunostimulants to enhance a variety of host immune responses, only a few studies have suggested that these substances are capable of preventing viral respiratory tract infections (5, 26) . RU 41740, a glycoprotein extract derived from the OjK2 strain of Klebsiella pneumoniae, has been shown to enhance both humoral and cell-mediated immune responses (7, 30, 31) and to reduce the frequency of infectious episodes in patients with chronic bronchitis (27) . In experimental models, administration of RU 41740 via the aerosol route for 5 consecutive days was found to protect mice against a lethal aerosol inoculation of influenza virus (24) . RU 41821 has been shown to be also a potent immunomodulating agent (7, 31) .
In the present study, we investigated the effects of two RU 41821 aerosol treatment schedules on the kinetics of the induction of bronchoalveolar cell populations, and we also analyzed the effect of RU 41821 on the luminol-dependent chemiluminescence (LDCL) response of alveolar macrophages engaged in the phagocytosis of opsonized zymosan. The correlations are examined between the cell population recovered in BAW fluids, the LDCL response to alveolar macrophages, and the protection afforded by RU 41821 against influenza virus infection. Zymosan (Sigma) was prepared at a concentration of 20 mg/ml by boiling in saline for 10 min, washed twice, and opsonized in fresh donor serum by incubation at 37°C for 30 min. The suspension of opsonized zymosan was resuspended in saline at a concentration of 10 mg/ml and stored in aliquots at -70°C until used. In ex vivo experiments, pulmonary lavages were aseptically performed 4 h after a single RU 41821 aerosol treatment. BAW cell suspensions from groups of 6 to 10 mice treated with either saline or RU 41821 were pooled. These cell suspensions were centrifuged at 200 x g and 4°C for 10 min and suspended in M199 (Flow Laboratories), supplemented with 20% fetal calf serum, penicillin, and streptomycin. Purified alveolar macrophages were obtained by 24-h adherence separation of the cell suspensions on plastic chemiluminescence vials, and nonadherent cells were washed away. After each chemiluminescence measurement, samples were checked for the absence of contaminating PMNs after cells had been detached from the vials by a trypsin-EDTA solution. This adherence enrichment procedure eliminated the possibility that PMNs might alter the results of LDCL studies (28, 29) and always permitted more than 99% recovery of alveolar macrophages.
LDCL was measured in a photometer (Luminometer 1251; LKB Wallac, Turku, Finland) at 37°C, with continuous stirring. Spontaneous chemiluminescence started with the addition of 100 ,ul of lumninol to 105 adherent macrophages and was recorded for 12 min. Induced chemiluminescence started with the addition of opsonized zymosan, and light emission was recorded for 16 min. LDCL was always measured in triplicate. The integral representing the total amount of light emitted during a selected time was calculated in millivolts by microcomputer. The statistical significance of the difference between measurements was assessed by a t test.
Virus. The influenza virus strain A/PR8 (HlNl) was adapted to Swiss mice by serial respiratory tract infections. After the final lung passage, the allantoic cavities of 9-dayold embryonated chicken eggs were inoculated with pooled supernatant fluids from infected lungs. Infected allantoic fluids were harvested 72 h later and stored in aliquots at -70°C until needed. Each sample contained 2.7 x 109 50% egg infectious doses per ml. Four hours after a single aerosol treatment, the only significant changes observed were in the total number of bronchoalveolar cells and in the number of PMNs. However, 24 h after this treatment, the total BAW cell count had risen about 10-fold, and all leukocyte subpopulations contributed to this significant increase.
Furthermore, the alveolar macrophages harvested after each of these two schedules displayed morphological changes, including increases in size and in the number of granules and a more vacuolated basophilic cytoplasm.
Chemiluminescence assay. As preliminary in vitro experiments showed that RU 41821 itself does not generate LDCL in alveolar macrophages (Fig. 1) , LDCL was tested on alveolar macrophages from mice pretreated in vivo with RU 41821.
The results show that a single RU 41821 aerosol treatment enhanced the generation of spontaneous chemiluminescence, since the low values obtained from treated mice were significantly different from those for the saline controls (P < 0.05). Consequently, alveolar macrophages from treated mice displayed a greatly enhanced chemiluminescence response to opsonized zymosan, compared with the saline controls (Fig. 2) .
Stimulation by RU 41821 of resistance against influenza virus. A viral challenge was performed 4 h after RU 41821 aerosol treatmnent for 5 consecutive days, and another was done 24 h after a single treatment (Fig. 3 and 4) . Both schedules afforded significant protection against the influenza virus-induced mortality of mice. However, the higher degree of resistance was observed after the 5-day treatment (P < 0.01).
DISCUSSION
The present results clearly demonstrate that the stimulation of various processes in the lung by RU 41821 aerosol treatment is reflected by the cell composition of BAW fluids. Exposure of mice to RU 41821 led to a fast, highl increase in the total number of bronchoalveolar 4 h. PMNs, alveolar macrophages, monocytes, C cytes are the morphological cell types whose at bers increased most consistently, but the m observed was the influx of PMNs. Similar PM? tion in BAW fluids has also been described a] intranasal instillation of endotoxin (8) or Cory parvum (17) . Alveolar macrophage-derived cher possible that RU 41821 also enhances the levels of colonynotactic facstimulating activity, thus enhancing the granulopoietic response. Our work demonstrates that another line of defensive cells, the lymphocytes, is mobilized in addition to PMNs. Of the 50 products released by activated macrophages (1), interleukin-1 appears to participate in the inflammatory response (14) and may be involved in the accumulation of lymphocytes in the alveolar spaces, where, in the normal steady state, these cells are rare.
Another interesting feature of the BAW fluids analyzed here is the increased number of alveolar macrophages seen after RU 41821 aerosol treatment for 5 consecutive days.
Earlier the intensified recruitment of these cells in response to Mycobacterium bovis BCG injection was found to be due to the influx of monocytes (20) . Our data also suggest that monocytes were mainly responsible for the larger number of alveolar macrophages seen after RU 41821 treatment, al-... C though an increased number of locally dividing macrophages interaction between macrophages and other cellular components of BAW fluids. Thus, Masihi et al. (19) reported that the mature T lymphocytes present in normal spleeh cell suspensions apparently augment the chemiluminescence response of spleen macrophages.
Finally, when the enhanced activity of RU 41821 was tested here by a viral challenge with an aerosol of mousepathogenic A/PR8 influenza virus, sighificant protection was afforded by both RU 41821 aerosol treatment schedules. However, the strongest protection was obtained in the mice exhibiting the largest increase in the total number of bronchoalveolar cells. It is therefore possible that in mice there is a link between the enhancement of resistance to influenza virus and the infiltration into the lungs of large numbers of leukocytes, especially PMNs. If such a relationship exists, it would resemble that reported by Martin et al. in humans (18) .
After influenza virus infection, inflammatory processes in the lurtgs are characterized by the infiltration not only of PMNs but also of macrophages and lymphocytes (33) . The pathology of influenza in the mouse is immune mediated (32) , with a substantial contribution from delayed-type hypersensitivity T lymphocytes (15) , whereas other categories of cells, i.e., NK cells (11) , "cytotoxic" macrophages (16) , and cytotoxic T lymphocytes (34) 
